Stimulants

Applications Controlled substance (stimulant). CNS stimulant from the same class as methylphenidate (M325880). Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Rivier, L., et al.: Anal. Chim. Acta, 492, 69 (2003), Politi, L., et al.: J. Anal. Toxicol., 29, 1 (2005),

Applications Controlled susbtancePiperazine derivative used as reference materials for forensic laboratories. They affect the central and the autonomic nervous systems, the blood pressure, and smooth muscle. References Bannwarth, W., et al.: Bioorg. Med. Chem., Lett., 6, 1525 (1996), Greenwald, R., et al.: J. Med. Chem., 43, 475 (2000), Wills, A., et al.: Curr. Opin. Chem. Biol., 7, 346 (2003), Heidler, P., et al.: Bioorg. Med. Chem., 13, 585 (2005),

Stability Hygroscopic, Light Sensitive Applications α-Pyrrolidinovalerophenone (PVP) is a stimulant compound developed in the 1960s and related to Pyrovalerone (P99775), which has been reported as a novel designer drug. References Fleckenstein, A., et al.: Eur. J. Pharmacol., 406, 1 (2000), Meltzer, P., et al.: J. Med. Chem., 44, 2619 (2001), Gorclick, D., et al.: Drugs, 64, 1547 (20040,

Applications Paraxanthine-d3, is the labeled analogue of Paraxanthine (P192500), an adenosine receptor ligand and a major metabolite of caffeine. References Proc. Natl. Acad. Sci. USA 78, 3260 (1981); Cell Mol. Neurobiol., 3, 69 (1983); Eur. J. Pharmacol., 179, 295 (1990)

Applications Controlled substance (stimulant). CNS stimulant. Four isomers of Methylphenidate are known to exist. One pair of threo isomers and one pair of erythro are distinguished, from which only d-threo-Methylphenidate exhibits the pharmacologically desired effects. This compound is a 4:1 mixture of DL-erythro to DL-threo. References Greenblatt, E.N., et al.: J. Pharmacol. Exp. Ther., 131, 115 (1961), Padmanabhan, G.R., Anal. Profiles Drug Subs., 10, 473 (1981), Srinivas, N.R., et al.: Pharm. Res., 10, 14 (1993),

Stability Hygroscopic Applications (R,S)-Norcotinine-pyridyl-d4 (cas# 1020719-70-3) is a compound useful in organic synthesis.

Applications Higenamine acts through inhibition of middle cerebral artery occlusion (MCAO)-mediated HMGB1 release in vivo. Useful towards ischemic injuries. References Ha, Y. et al.: Apoptosis., 17, 463 (2012);

Stability Hygroscopic Applications A tobacco alkaloid as risk factor of human cancer. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Stepanov, I., et al.: Cancer Res., 69, 8236 (2009), Maertens, R., et al.: Chem. Res. Toxicol., 22, 1406 (2009), Gaworski, C., et al.: Toxicol., 269, 54 (2010),

Applications 4-[N-(Methyl-d3)-N-nitrosamino]-4-(3-pyridyl)butane-1-ol is labelled 4-(N-Methyl-N-nitrosamino)-4-(3-pyridyl)butane-1-ol (M325700) which a toxic and carcinogenic labelled agent in dry and moist snuff. References Idris, A.M., et al.: Carcinogenesis, 13, 1001 (1992), Ren Q., et al.: Drug Metab. Dispos., 28, 1352 (2000), Brown, B., et al.: Mutat. Res., 494, 21 (2001),

Applications A Pyrovalerone (P997750) analog as selective dopamine transporter inhibitors. References Meltzer, P., et al.: Bioorg. Med. Chem., 10, 3583 (2002), Madras, B., et al.: Eur. J. Pharmacol., 479, 41 (2003), Carroll, F., et al.: J. Med. Chem., 47, 296 (2004),

Applications Diclofensine is a stimulant; inhibits reuptake of dopamine and noradrenaline, is an effective antidepressant. Diclofensine exhibits significant addictive properties. References Supersaxo, A., et al.: Pharm. Res., 8, 1286 (1991), Nakachi, N., et al.: Eur. J. Pharmacol., 281, 195 (1995), Chankvetadze, B., et al.: J. Pharm. Biomed. Anal., 27, 467 (2001),

Applications (±)-Cotinine-2,4,5,6-d4 (pyridine-d4) (CAS# 350818-68-7) is a useful isotopically labeled research compound.